Marbofloxacin is a synthetic fluoroquinolone antibiotic primarily used in veterinary medicine as a broad-spectrum antimicrobial agent. It is effective against a wide range of Gram-positive and Gram-negative bacterial infections in animals, including cattle, pigs, dogs, and cats. The compound is commonly administered to treat respiratory tract infections, urinary tract infections, skin and soft tissue infections, and bacterial arthritis caused by susceptible bacteria. Its potent bactericidal properties, excellent tissue penetration, and activity against pathogens resistant to other antibiotics make it a valuable tool in managing bacterial diseases in livestock and companion animals, contributing to improved animal health and productivity. Proper dosage, adherence to withdrawal periods, and veterinary supervision are essential to ensure safety, efficacy, and to prevent the development of antibiotic resistance.